The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in Oman.

Salman, Bushra; AlWard, Nameer M; Al-Hashami, Zamzam; Al-Sharqi, Hadil; Al-Sayegh, Hasan; Burney, Ikram A

Salman, Bushra; AlWard, Nameer M; Al-Hashami, Zamzam; Al-Sharqi, Hadil; Al-Sayegh, Hasan; Burney, Ikram A.

Afiliación

Salman B; Pharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, OMN.
AlWard NM; Pharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, OMN.
Al-Hashami Z; Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, OMN.
Al-Sharqi H; Pharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, OMN.
Al-Sayegh H; Research Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, OMN.
Burney IA; Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, OMN.

Cureus ; 15(10): e47050, 2023 Oct.

Article en En | MEDLINE | ID: mdl-38021572

Palabras clave

cancer; immune checkpoint inhibitors; immune-related adverse effects; middle east; oncology; sultanate of oman

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google